Key Insights

Highlights

Success Rate

99% trial completion (above average)

Published Results

18 trials with published results (12%)

Research Maturity

85 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.7%

1 terminated out of 148 trials

Success Rate

98.8%

+12.3% vs benchmark

Late-Stage Pipeline

18%

27 trials in Phase 3/4

Results Transparency

21%

18 of 85 completed with results

Key Signals

18 with results99% success

Data Visualizations

Phase Distribution

135Total
Not Applicable (43)
Early P 1 (2)
P 1 (26)
P 2 (37)
P 3 (21)
P 4 (6)

Trial Status

Completed85
Unknown24
Not Yet Recruiting15
Recruiting9
Withdrawn9
Active Not Recruiting4

Trial Success Rate

98.8%

Benchmark: 86.5%

Based on 85 completed trials

Clinical Trials (148)

Showing 20 of 20 trials
NCT07563036Not ApplicableRecruitingPrimary

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

NCT07529977Phase 3Not Yet RecruitingPrimary

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

NCT06648850Phase 2Not Yet Recruiting

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

NCT07518342Phase 4Not Yet RecruitingPrimary

The Effect of Nanofat Injection on Androgenetic Alopecia

NCT07490327Phase 1Not Yet RecruitingPrimary

Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia

NCT07294313Not Yet RecruitingPrimary

Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study

NCT07482423Phase 1Not Yet RecruitingPrimary

XVIE to Treat Androgenetic Alopecia (AGA)

NCT07080931Phase 3RecruitingPrimary

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

NCT07433933Completed

Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.

NCT07429253Phase 1RecruitingPrimary

Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients

NCT06972264Phase 3Active Not RecruitingPrimary

Safety and Efficacy of VDPHL01 in Males With AGA

NCT06927960Phase 1CompletedPrimary

Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration

NCT06393452Phase 2CompletedPrimary

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

NCT04594018Phase 3RecruitingPrimary

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

NCT07248410Not ApplicableNot Yet RecruitingPrimary

A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of Androgenetic Alopecia

NCT07146022Phase 3Recruiting

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

NCT06527365Phase 2Active Not RecruitingPrimary

Safety and Efficacy of VDPHL01 in Males and Females With AGA

NCT06724614Phase 2Active Not RecruitingPrimary

Efficacy and Safety of VDPHL01 in Males With AGA

NCT07155408Not ApplicableCompletedPrimary

Combined Use of Povidone-Iodine and Rifampicin in Hair Transplantation

NCT04209803Phase 4CompletedPrimary

N-Acetyl-Cysteine for Treatment of AGA in Men

Scroll to load more

Research Network

Activity Timeline